Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness

J Exp Med. 1995 Aug 1;182(2):439-47. doi: 10.1084/jem.182.2.439.

Abstract

Major histocompatibility complex (MHC) class I molecules are cell-surface proteins that present peptides to CD8+ T cells. These peptides are mostly derived from endogenously synthesized protein. Recombinant, soluble MHC class I molecules were produced, purified, and loaded homogeneously with synthetic peptide. These MHC-peptide complexes were used to activate a T cell hybridoma. While monomers of MHC-peptide bound to the T cell, they showed no stimulatory activity. Dimers fully triggered the T cell hybridoma to secrete interleukin 2. This response was followed by a state in which the T cell was refractory to restimulation as a result of defective signal transduction through the T cell receptor.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • H-2 Antigens / chemistry*
  • H-2 Antigens / immunology
  • Hybridomas
  • In Vitro Techniques
  • Lymphocyte Activation*
  • Macromolecular Substances
  • Mice
  • Molecular Sequence Data
  • Peptides / immunology
  • Protein Binding
  • Receptors, Antigen, T-Cell / physiology*
  • Signal Transduction
  • Solubility
  • Structure-Activity Relationship
  • T-Lymphocytes, Cytotoxic / immunology*
  • Time Factors

Substances

  • H-2 Antigens
  • Macromolecular Substances
  • Peptides
  • Receptors, Antigen, T-Cell